{"studyId":"brca_mapk_hp_msk_2021","cancerTypeId":"brca","name":"MAPK on resistance to anti-HER2 therapy for breast cancer (MSK, Nat Commun. 2022)","description":"MSK-IMPACT targeted sequencing of 145 breast tumors with matched normal samples.","publicStudy":true,"pmid":"34795269","citation":"Alison E et al.  Nat Commun 2022","groups":"","status":1,"importDate":"2026-04-07 00:39:33","allSampleCount":145,"sequencedSampleCount":145,"cnaSampleCount":145,"mrnaRnaSeqSampleCount":0,"mrnaRnaSeqV2SampleCount":0,"mrnaMicroarraySampleCount":0,"miRnaSampleCount":0,"methylationHm27SampleCount":0,"rppaSampleCount":0,"massSpectrometrySampleCount":0,"completeSampleCount":0,"referenceGenome":"hg19","treatmentCount":36,"structuralVariantCount":43,"cancerType":{"id":"brca","name":"Invasive Breast Carcinoma","dedicatedColor":"HotPink","shortName":"BRCA","parent":"breast"},"readPermission":true,"resourceCounts":[]}